Short‐term hypoxia upregulated Mas receptor expression to repress the AT1R signaling pathway and attenuate Ang II‐induced cardiomyocyte apoptosis

Hypertension‐stimulated cardiac hypertrophy and apoptosis play critical roles in the progression of heart failure. Our previous study suggested that hypertensive angiotensin II (Ang II) enhanced insulin‐like growth factor receptor II (IGF‐IIR) expression and cardiomyocyte apoptosis, which are involved JNK activation, sirtuin1 (SIRT1) degradation, and heat‐shock transcription factor 1 (HSF1) acetylation. Moreover, previous studies have implied that short‐term hypoxia (STH) might exert cardioprotective effects. However, the effects of STH on Ang II‐induced cardiomyocyte apoptosis remain unknown. In this study, we found that STH reduced myocardial apoptosis caused by Ang II via upregulation of the Mas receptor (MasR) to inhibit the AT1R signaling pathway. STH activates MasR to counteract the Ang II pro‐apoptotic signaling cascade by inhibiting IGF‐IIR expression via downregulation of JNK activation and reduction of SIRT1 degradation. Hence, HSF could remain deacetylated, and repress IGF‐IIR expression. These effects decrease the activation of downstream pro‐apoptotic and hypertrophic cascades and protect cardiomyocytes from Ang II‐induced injury. In addition, we also found that silencing MasR expression enhanced Ang II‐induced cardiac hypertrophy and the apoptosis signaling pathway. These findings suggest a critical role for MasR in cardiomyocyte survival. Altogether, our findings indicate that STH protects cardiomyocytes from Ang II‐stimulated apoptosis. The protective effects of STH are associated with the upregulation of MasR to inhibit AT1R signaling. STH could be a potential therapeutic strategy for cardiac diseases in hypertensive patients.

[1]  K. Rodgers,et al.  Long-term administration of angiotensin (1-7) prevents heart and lung dysfunction in a mouse model of type 2 diabetes (db/db) by reducing oxidative stress, inflammation and pathological remodeling. , 2016, Pharmacological research.

[2]  D. Kuster,et al.  β‐adrenergic receptor signalling and its functional consequences in the diseased heart , 2016, European journal of clinical investigation.

[3]  W. Kuo,et al.  Angiotensin-(1-7) attenuated long-term hypoxia-stimulated cardiomyocyte apoptosis by inhibiting HIF-1α nuclear translocation via Mas receptor regulation , 2016, Growth factors.

[4]  S. Stacker Growth factors: the journey continues , 2016, Growth factors.

[5]  Jun Ren,et al.  Mas receptor mediates cardioprotection of angiotensin‐(1‐7) against Angiotensin II‐induced cardiomyocyte autophagy and cardiac remodelling through inhibition of oxidative stress , 2015, Journal of cellular and molecular medicine.

[6]  W. Kuo,et al.  Diallyl trisulfide protects against high glucose-induced cardiac apoptosis by stimulating the production of cystathionine gamma-lyase-derived hydrogen sulfide. , 2015, International journal of cardiology.

[7]  W. Kuo,et al.  Long-term hypoxia exposure enhanced IGFBP-3 protein synthesis and secretion resulting in cell apoptosis in H9c2 myocardial cells , 2015, Growth factors.

[8]  W. Kuo,et al.  Prolactin protects cardiomyocytes against intermittent hypoxia-induced cell damage by the modulation of signaling pathways related to cardiac hypertrophy and proliferation. , 2015, International journal of cardiology.

[9]  Shinn-Zong Lin,et al.  Sambucus williamsii induced embryonic stem cells differentiated into neurons , 2015, BioMedicine.

[10]  Zhi‐hong Wang Anti-glycative effects of asiatic acid in human keratinocyte cells , 2014, BioMedicine.

[11]  Shin-Da Lee,et al.  Protective effect of salidroside on cardiac apoptosis in mice with chronic intermittent hypoxia. , 2014, International journal of cardiology.

[12]  W. Kuo,et al.  ANG II promotes IGF-IIR expression and cardiomyocyte apoptosis by inhibiting HSF1 via JNK activation and SIRT1 degradation , 2014, Cell Death and Differentiation.

[13]  F. Tsai,et al.  Inhibitory effect of alpinate Oxyphyllae fructus extracts on Ang II-induced cardiac pathological remodeling-related pathways in H9c2 cardiomyoblast cells , 2013 .

[14]  F. Tsai,et al.  Dung-shen (Codonopsis pilosula) attenuated the cardiac-impaired insulin-like growth factor II receptor pathway on myocardial cells. , 2013, Food chemistry.

[15]  S. Gong,et al.  Role of mitochondrial damage during cardiac apoptosis in septic rats , 2013, Chinese medical journal.

[16]  Liang-Yi Si,et al.  Hypoxia-inducible factor-1α and vascular endothelial growth factor in the cardioprotective effects of intermittent hypoxia in rats , 2013, Upsala journal of medical sciences.

[17]  S. Nicklin,et al.  Adenoviral Delivery of Angiotensin-(1-7) or Angiotensin-(1-9) Inhibits Cardiomyocyte Hypertrophy via the Mas or Angiotensin Type 2 Receptor , 2012, PloS one.

[18]  S. Guatimosim,et al.  Angiotensin-(1-7)-Mediated Signaling in Cardiomyocytes , 2012, International journal of hypertension.

[19]  J. Mocco,et al.  Lentivirus‐mediated overexpression of angiotensin‐(1–7) attenuated ischaemia‐induced cardiac pathophysiology , 2011, Experimental physiology.

[20]  J. Poelaert,et al.  SEPSIS AND SEPTIC SHOCK: PATHOPHYSIOLOGICAL AND CARDIOVASCULAR BACKGROUND AS BASIS FOR THERAPY , 2010, Acta clinica Belgica.

[21]  F. Tsai,et al.  Activation of insulin-like growth factor II receptor induces mitochondrial-dependent apoptosis through G(alpha)q and downstream calcineurin signaling in myocardial cells. , 2009, Endocrinology.

[22]  F. Tsai,et al.  Enhancement of AG1024-induced H9c2 cardiomyoblast cell apoptosis via the interaction of IGF2R with Galpha proteins and its downstream PKA and PLC-beta modulators by IGF-II. , 2009, The Chinese journal of physiology.

[23]  F. Tsai,et al.  Short-term versus long-term intermittent hypobaric hypoxia on cardiac fibrosis and Fas death receptor dependent apoptotic pathway in rat hearts. , 2008, The Chinese journal of physiology.

[24]  F. Tsai,et al.  IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via Galphaq interaction and protein kinase C-alpha/CaMKII activation in H9c2 cardiomyoblast cells. , 2008, The Journal of endocrinology.

[25]  F. Tsai,et al.  The coexistence of nocturnal sustained hypoxia and obesity additively increases cardiac apoptosis. , 2008, Journal of applied physiology.

[26]  B. Tzang,et al.  More Activated Cardiac Mitochondrial‐dependent Apoptotic Pathway in Obese Zucker Rats , 2007, Obesity.

[27]  F. Tsai,et al.  Cardiac Fas Receptor‐dependent Apoptotic Pathway in Obese Zucker Rats , 2007, Obesity.

[28]  Shin-Da Lee,et al.  Effects of long-term intermittent hypoxia on mitochondrial and Fas death receptor dependent apoptotic pathways in rat hearts. , 2007, International journal of cardiology.

[29]  F. Tsai,et al.  Eccentric cardiac hypertrophy was induced by long‐term intermittent hypoxia in rats , 2007, Experimental physiology.

[30]  N. Alenina,et al.  Effects of genetic deletion of angiotensin-(1-7) receptor Mas on cardiac function during ischemia/reperfusion in the isolated perfused mouse heart. , 2006, Life sciences.

[31]  Shin-Da Lee,et al.  Roles of insulin-like growth factor II in cardiomyoblast apoptosis and in hypertensive rat heart with abdominal aorta ligation. , 2006, American journal of physiology. Endocrinology and metabolism.

[32]  Chieh-Hsi Wu,et al.  Cardiomyoblast apoptosis induced by insulin-like growth factor (IGF)-I resistance is IGF-II dependent and synergistically enhanced by angiotensin II , 2006, Apoptosis.

[33]  N. Alenina,et al.  Impairment of In Vitro and In Vivo Heart Function in Angiotensin-(1-7) Receptor Mas Knockout Mice , 2006, Hypertension.

[34]  Chieh-Hsi Wu,et al.  Serum MMP-9 activity as a diagnosing marker for the developing heart failure of post MI patients. , 2006, The Chinese journal of physiology.

[35]  Chieh-Hsi Wu,et al.  Effects of short- and long-term hypobaric hypoxia on Bcl2 family in rat heart. , 2006, International journal of cardiology.

[36]  H. Ding,et al.  Intermittent hypoxia attenuates ischemia/reperfusion induced apoptosis in cardiac myocytes via regulating Bcl-2/Bax expression , 2003, Cell Research.

[37]  P. Kang,et al.  Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases. , 2003, Trends in molecular medicine.

[38]  Arantxa González,et al.  Stimulation of Cardiac Apoptosis in Essential Hypertension: Potential Role of Angiotensin II , 2002, Hypertension.

[39]  J. Díez,et al.  Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. , 1997, Hypertension.

[40]  E. Lakatta,et al.  Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. , 1997, The American journal of physiology.

[41]  L. Richard,et al.  Apoptosis in target organs of hypertension. , 1995, Hypertension.

[42]  Qinghua Wu,et al.  Infusion of esmolol attenuates lipopolysaccharide-induced myocardial dysfunction. , 2016, The Journal of surgical research.

[43]  K. Griendling,et al.  Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. , 2007, American journal of physiology. Cell physiology.

[44]  T. N. James,et al.  On the nature of cell death during remodeling of hypertrophied human myocardium. , 2000, Journal of molecular and cellular cardiology.